ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
CNTESAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health announced initiation of patient enrollment for a landmark UK clinical study utilizing its Avantect Pancreatic Cancer Test.
June 16, 2025Clinical Trials
Read more →